BRANDYWINE REALTY TRUST (BDN)

US1053682035 - REIT

4.47  +0.07 (+1.59%)

After market: 4.47 0 (0%)

Fundamental Rating

3

Taking everything into account, BDN scores 3 out of 10 in our fundamental rating. BDN was compared to 126 industry peers in the Diversified REITs industry. Both the profitability and financial health of BDN have multiple concerns. BDN has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

In the past year BDN has reported negative net income.
In the past year BDN had a positive cash flow from operations.
Of the past 5 years BDN 4 years were profitable.
Each year in the past 5 years BDN had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -5.29%, BDN is not doing good in the industry: 91.06% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -14.98%, BDN is doing worse than 91.06% of the companies in the same industry.
BDN's Return On Invested Capital of 2.25% is in line compared to the rest of the industry. BDN outperforms 42.28% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BDN is in line with the industry average of 2.95%.
The 3 year average ROIC (2.11%) for BDN is below the current ROIC(2.25%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -5.29%
ROE -14.98%
ROIC 2.25%
ROA(3y)-1.2%
ROA(5y)1.01%
ROE(3y)-3.66%
ROE(5y)1.61%
ROIC(3y)2.11%
ROIC(5y)2.19%

1.3 Margins

BDN has a Operating Margin (19.66%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BDN has declined.
The Gross Margin of BDN (63.10%) is worse than 65.85% of its industry peers.
In the last couple of years the Gross Margin of BDN has remained more or less at the same level.
Industry RankSector Rank
OM 19.66%
PM (TTM) N/A
GM 63.1%
OM growth 3Y-1.77%
OM growth 5Y-2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.82%
GM growth 5Y1.17%

3

2. Health

2.1 Basic Checks

BDN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BDN has more shares outstanding than it did 1 year ago.
BDN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BDN has a worse debt to assets ratio.

2.2 Solvency

BDN has an Altman-Z score of -0.25. This is a bad value and indicates that BDN is not financially healthy and even has some risk of bankruptcy.
BDN has a Altman-Z score of -0.25. This is amonst the worse of the industry: BDN underperforms 89.43% of its industry peers.
The Debt to FCF ratio of BDN is 163.69, which is on the high side as it means it would take BDN, 163.69 years of fcf income to pay off all of its debts.
BDN's Debt to FCF ratio of 163.69 is in line compared to the rest of the industry. BDN outperforms 42.28% of its industry peers.
BDN has a Debt/Equity ratio of 1.62. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.62, BDN is doing worse than 68.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.62
Debt/FCF 163.69
Altman-Z -0.25
ROIC/WACC0.31
WACC7.26%

2.3 Liquidity

BDN has a Current Ratio of 1.48. This is a normal value and indicates that BDN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.48, BDN is in line with its industry, outperforming 59.35% of the companies in the same industry.
A Quick Ratio of 1.48 indicates that BDN should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.48, BDN is doing good in the industry, outperforming 63.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48

3

3. Growth

3.1 Past

The earnings per share for BDN have decreased strongly by -470.97% in the last year.
The Revenue has been growing slightly by 1.69% in the past year.
Measured over the past years, BDN shows a decrease in Revenue. The Revenue has been decreasing by -1.11% on average per year.
EPS 1Y (TTM)-470.97%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-635.29%
Revenue 1Y (TTM)1.69%
Revenue growth 3Y-1.28%
Revenue growth 5Y-1.11%
Revenue growth Q2Q0.91%

3.2 Future

The Earnings Per Share is expected to grow by 21.80% on average over the next years. This is a very strong growth
Based on estimates for the next years, BDN will show a small growth in Revenue. The Revenue will grow by 1.42% on average per year.
EPS Next Y65.46%
EPS Next 2Y32.44%
EPS Next 3Y21.8%
EPS Next 5YN/A
Revenue Next Year2.97%
Revenue Next 2Y3.74%
Revenue Next 3Y4.32%
Revenue Next 5Y1.42%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

BDN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BDN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

88.62% of the companies in the same industry are more expensive than BDN, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as BDN.
Industry RankSector Rank
P/FCF 58.94
EV/EBITDA 9.79

4.3 Compensation for Growth

A more expensive valuation may be justified as BDN's earnings are expected to grow with 21.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.44%
EPS Next 3Y21.8%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 13.30%, BDN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.12, BDN pays a better dividend. On top of this BDN pays more dividend than 96.75% of the companies listed in the same industry.
BDN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 13.3%

5.2 History

The dividend of BDN decreases each year by -0.08%.
BDN has been paying a dividend for at least 10 years, so it has a reliable track record.
BDN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-0.08%
Div Incr Years1
Div Non Decr Years13

5.3 Sustainability

The earnings of BDN are negative and hence is the payout ratio. BDN will probably not be able to sustain this dividend level.
DP-62.97%
EPS Next 2Y32.44%
EPS Next 3Y21.8%

BRANDYWINE REALTY TRUST

NYSE:BDN (4/26/2024, 3:15:00 PM)

After market: 4.47 0 (0%)

4.47

+0.07 (+1.59%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap770.05M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 13.3%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.29%
ROE -14.98%
ROCE
ROIC
ROICexc
ROICexgc
OM 19.66%
PM (TTM) N/A
GM 63.1%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.62
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-470.97%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y65.46%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.69%
Revenue growth 3Y-1.28%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y